Pfizer to seek approval from FDA 'within days' after further analysis finds COVID-19 vaccine 95% effective
Pfizer and BioNTech are expected to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.
Pfizer to seek approval from FDA 'within days' after further analysis finds COVID-19 vaccine 95% effective
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?
Newsy
Watch VideoThe need for a COVID vaccine is greater than ever before as cases surge and hospitals are overwhelmed in much of the..
-
Moderna asking US, European regulators to greenlight COVID-19 vax
Mid-Day
-
UK stocks up on vaccines, hopes to start virus shots in days
SeattlePI.com
-
UK appoints vaccines minister to oversee COVID inoculations
SeattlePI.com
-
Mumbai travel firm offers US holiday package for Rs 1.75 lakh with promise of COVID-19 vaccine
Mid-Day
Advertisement
More coverage
Who Will Get The First 6.4 Million Doses Of COVID-19 Vaccine?
Newsy
Watch VideoWe've been hearing for weeks how supply will be limited at first for any approved COVID vaccine. The experts think once..
-
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
US benchmarks start the week higher as more vaccine optimism cheers traders
Proactive Investors
-
US stocks seen pushing higher as optimism grows that coronavirus vaccines will soon be rolled out
Proactive Investors